Directory

Nanocopoeia is a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products. The business of Nanocopoeia is the therapeutic use of those nanoparticles in medical applications. Our patented ElectroNanospray™ (ENS) process is currently being used to produce complex coatings for medical devices and to nanoformulate drugs.

The aim of MARINA is to develop and validate the Risk Management Methods for Nanomaterials.

To do this, MARINA will address the four central themes for the Risk Assessment and Management of Nanomaterials: Materials, Exposure, Hazard, and Risk. In MARINA we will develop beyond state-of-the-art referential tools from each of these themes and integrate them into a Risk Management Toolbox and Strategy for both human and environmental health.

Magnolia Solar, Inc. strives to develop and produce low cost, high efficiency, thin film solar cell modules. Our goal is to make strong impact towards green technology.

Magnolia´s thin film solar cells offer - substantially lower cost than crystalline solar cells, use less expensive materials, significant gains in efficiency vs. other thin film cells and modules by application of proprietary nano/micro technologies; and, has the potential for lowest cost/watt solar technology.

World-wide supplier of specialist paints, plating processes and equipment to the Surface finishing industry.

The Birck Nanotechnology Center leverages advances in nanoscale science and engineering to create innovative nanotechnologies addressing societal challenges and opportunities in computing, communications, the environment, security, energy independence, and health. In turn, the Birck Nanotechnology Center exploits the accelerating progress in nanotechnology utilizing the most advanced nanoscale instrumentation to pursue answers to fundamental questions in the life and physical sciences.

Focused on novel, nanotechnology-based therapeutics.

Cerulean Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the design and development of nanopharmaceuticals. Cerulean’s nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance efficacy and tolerability of therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules.

Cerulean is pursuing three key strategies:

Eclipse is focused on the advancement of nano-thin film techniques and related equipment technology to solve challenges encountered by select customers.
Eclipse combines a unique blend of scientific and engineering expertise with common sense solutions for a broad range of terrestrial and space based applications.

The UC Center for Environmental Implications of Nanotechnology (UC CEIN) studies the effects of nanomaterials on a range of biological systems in terrestrial, freshwater, and marine environments. From this research, the UC CEIN will design a comprehensive risk-ranking model, based on the potential toxicity, mobility, and persistence of the nanomaterials. With the rapid development of nanotechnology, little is known about the possible environmental, health, and safety impacts of nanomaterials.